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Exercise Assessment for People with End-stage Renal Failure 
Dr Pelagia Koufaki and Professor Tom Mercer 
Introduction 
 Progressive loss of kidney function is often described as chronic kidney disease 
(CKD). Chronic kidney disease may progress to end stage renal failure (ESRF), at which 
point the kidneys are not able to perform their regulatory and excretory functions. The 
transition into end-stage renal failure, with the concomitant derangement of normal 
biochemical, metabolic and endocrine functions, is almost always accompanied by the 
clinical syndrome of uraemia. Symptoms such as anorexia, generalised lethargy and 
fatigue, sleep disorder, neurological dysfunction, nausea and vomiting are frequently 
evident. The appearance of these symptoms is remarkably consistent and appears to 
coincide with abnormal plasma levels of many substances including urea, creatinine, 
phosphate, and parathyroid hormone, which have been identified as potential uraemic 
toxins. Accompanying clinical signs of ESRF include fluid retention (peripheral and 
pulmonary oedema), raised blood pressure, diminishing haemoglobin levels and 
abnormal biochemistry (creatinine, serum urea and potassium) (Bommer 1992, Moore 
2000).  
The partial or complete loss of kidney function requires that some form of renal 
replacement therapy be initiated to maintain life. Renal replacement therapy refers to 
treatments that aim to remove excess fluid and waste products from the body (dialysis or 
kidney transplantation) and administration of drugs to supplement residual kidney 
functions, or manage the effects of lack of kidney functions (UK Renal Registry 2002). 
Haemodialysis (HD) and continuous ambulatory peritoneal dialysis (PD) are the principal 
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dialysis techniques commonly used. The former involves the removal of excess fluid and 
toxic solutes from the blood through a dialysis machine (artificial kidney). Peritoneal 
dialysis utilises the peritoneal cavity, and a permanently implanted catheter, as the means 
by which the exchange of toxic metabolic by products and removal of excess waste is 
achieved.  For details on the differences between dialysis techniques the interested reader 
may refer to the Oxford Handbook of Dialysis (Levy et al, 2004).   The guidelines 
discussed in this chapter refer only to patients undergoing dialysis therapy.  
 
Pathophysiology and Physical Dysfunction in End-stage Renal failure 
Kidney disease is associated with multi-systemic dysfunction including 
abnormalities of the cardiovascular, endocrine-metabolic and musculoskeletal systems, 
electrolyte and acid base imbalances, neurological, haematological and psychosocial 
disorders (Moore 2000).  Renal failure may result as a consequence of underlying and/or 
pre-existing conditions such as diabetes, arteriosclerotic renovascular disease, genetic 
defects or kidney infections. Conversely, established renal failure itself may precipitate 
the development of co-existing conditions including ischaemic heart disease, peripheral 
vascular disease and heart failure. This produces a complex pathophysiology for each 
individual patient with ESRF that will influence the choice of dialysis mode, may reduce 
the effectiveness of dialysis therapy and ultimately will dictate clinical outcome.   
In addition, to the restrictions imposed by the multi-systemic dysfunction and the 
dialysis treatment itself, patients with ESRF are commonly physical inactive and 
characterised by limited levels of physical functioning (Deligiannis et al. 1999, Johansen 
et al. 2000).  As a result, patients with ESRF have significantly reduced levels of exercise 
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capacity. Typically, mean VO2 peak is around 19 ml·kg-1·min-1 and ranges from 13 – 28 
ml·kg-1·min-1. This corresponds to ~65% of values reported for age, gender and physical 
activity-matched healthy controls (Moore et al. 1993, Kouidi et al. 1998, Deligiannis et 
al. 1999, Koufaki et al. 2002). Objective measurement of functional capacity, using 
reliable and validated tests, reveals an even greater degree of impairment of ESRF 
patients in relation to activities of daily living. Deficits ranging from 20-120% have been 
observed, especially in the older dialysis population, indicating that the extent of 
functional impairment may be greatly underestimated if one relies only on physiological 
measures of peak exercise capacity (Naish et al. 2000, Painter et al 2000).  
Correlates and “predictors” of physical function in ESRF include: sedentary life 
style, cardiovascular comorbidity, number of additional comorbidities, age, serum 
albumin, serum creatinine, dialysis dose, nutritional status, muscle atrophy, muscle 
strength, dialysis age, functional capacity, systemic inflammation (Moore et al. 1993, 
Johansen et al. 2001, Sietesema et al. 2002, Johansen et al. 2003). Whilst these 
observations confirm the multi-systemic effects of renal disease they also highlight the 
difficulties of establishing a single best approach to characterise physical dysfunction in 
these patients. Nonetheless, it is imperative that any safe and accurate assessment of 
physical function must be conducted within the context of appropriate risk factor 
stratification. This must take into account the patient’s medical history, the prevailing 
clinical picture and their life style.  The choice of the most informative and feasible 
method of functional assessment should then be reviewed on an individual basis, bearing 
in mind that for some patients exercise assessment will be contraindicated (see Table 1). 
*********** INSERT TABLE 1 ABOUT HERE******************  
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Exercise Tolerance assessment 
The specific choice and type of protocol for physical function assessment will 
mainly depend on the primary purpose of the assessment (diagnostic, exercise training 
prescription, risk stratification etc). The execution of comprehensive physiological 
exercise testing that includes measures of gas exchange, cardiac function, systemic blood 
pressure monitoring and patients’ subjective responses to general and specific discomfort 
(Ratings of perceived exertion, angina and breathlessness scales) is considered to be the 
“gold standard” of exercise capacity assessment for ambulatory patients on dialysis. 
Measures of VO2 peak and VO2 at lactate threshold (LT) obtained during this type of test 
can be used to:  
• Establish physiological impairment and determine prognosis  
• Categorise patients to different risk factor groups 
• Evaluate the presence and severity of symptoms 
• Identify potential life threatening situations 
• Determine safe and effective exercise rehabilitation intensities 
• Evaluate responses to interventions 
 
It is vital that patients fully understand the procedures, reasons and possible “side effects” 
associated with all tests and agree to execute them. It is also essential that patients are 
given adequate opportunity to be habituated to all protocols and equipment.  Although all 
conventional guidelines for the conduct of graded exercise testing of people with chronic 
disease need to be applied some additional ESRF condition-specific pre-testing 
considerations are highlighted in table 2. In particular patients should always be tested 
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“on” their usual regime of medication unless indicated otherwise by their physician.   
 
**************** INSERT TABLE 2 ABOUT HERE******************** 
 
Peak exercise capacity: The most commonly reported measures of integrated 
cardiorespiratory exercise capacity in patients with ESRF are peak VO2, peak heart rate, 
peak power output and time to exhaustion, obtained during incremental treadmill or cycle 
ergometer protocols (Moore et al. 1993, Deligiannis et al. 1999, Koufaki et al. 2001).  
The clinical value of peak exercise capacity assessment for patients with ESRF is 
underscored by a recent report indicating that VO2 peak (>17.5 ml·kg-1·min-1) was a in 
fact a stronger predictor of survival than many traditional prognostic variables, some of 
which are subject to ceiling effects (Seitsema et al, 2004). 
 
Exercise test mode: Cycle ergometers are the most frequently used mode of exercise 
testing in patients with ESRF. The main advantage of cycle ergometry is that the 
monitoring of ECG and BP responses are more easily achieved. Moreover, patients with 
orthopaedic limitations and impaired balance or orthostatic intolerance may feel more 
confident exercising in a seated position. On the other hand, treadmill-walking protocols 
more closely mimic activities of daily living that are familiar to patients and may also 
prevent earlier termination of the test because of localised leg fatigue, a frequently 
reported cause of patient discomfort and test termination. 
Typically, a period of at least 2-3 min of unloaded exercise is required as a warm 
up, after which small increments of about 10-15 watts.min-1 should be applied to ensure 
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that peak performance capacity is reached after a total of 12-15 minutes of exercise. The 
increase in exercise intensity (or power output) can be applied either in a step or ramp 
fashion. In contrast, Kouidi (2001) advocates a longer duration protocol for the 
assessment of peak exercise capacity and has described a peak exercise capacity treadmill 
assessment protocol (Nephron - a modification of the Bruce treadmill protocol) that they 
have developed successfully used for over 10 years with patients with ESRF. Regardless 
of the protocol employed careful and continuous monitoring of all physiological 
responses is essential in order that adverse events be avoided and/or minimised during 
exercise assessment. Table 3 outlines abnormal responses that would indicate termination 
of the exercise test. Following the cessation of the peak exercise test patients should be 
encouraged to complete a gradual, active return to the non-exercising state (of at least 3 
minutes duration), during which monitoring of all assessed variables is continued. 
Patients should remain supervised in the assessment area until all indices of 
cardiovascular function have stabilised to pre-exercise or resting levels.  
*********** INSERT TABLE 3 ABOUT HERE******************  
 
Reproducibility information on exercise tolerance assessment and outcome 
measures in patients with ESRF is scarce in the literature. The only published study 
(Koufaki et al. 2001) that has evaluated the reproducibility of peak exercise parameters 
during incremental cycle ergometry, on a representative sample of contemporary dialysis 
patients, reported coefficients of variation of 4.7 % for VO2 peak, 9% for peak power 
output, 5.9% for peak HR and 13% for exercise test duration. These observations were 
based on repeated assessments, on non-dialysis days, for a group of maintenance dialysis 
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patients characterised by stable fluid status and resting haemodynamics. There is no 
published information available regarding the estimation of VO2 peak values from 
incremental exercise tests where gas exchange data has not been recorded.  
 
Submaximal exercise capacity: Peak exercise capacity measures provide valuable 
information on the upper limits of integrated cardio-respiratory physiology. However, 
that information may not necessarily reflect the ability of patients to perform activities of 
daily living. Functional independence is also associated with the ability to sustain tasks 
without experiencing fatigue and this information may be more easily and safely derived 
from sub-maximal exercise tests (Basset and Howley 2000). 
Measurement and/or estimation of lactate threshold (LT) using gas exchange data 
(GET/VT) during the execution of an incremental test is feasible and exhibits good 
reproducibility in patients undergoing dialysis. An important pre-test requirement for 
accurate and reliable measurement of these parameters is that standard clinical chemistry 
values are within the normal range for dialysis patients (for normal ranges see Oxford 
Handbook of Dialysis, 2004). Indicative CV% for VO2 at VT, time at VT, power output 
at VT and HR at VT are 6.6%, 11.7%, 9.7% and 4.9% respectively (Koufaki et al. 2001). 
The use of sub-maximal indices associated with physiological anchor points, such as VT 
or LT are also less likely to be influenced by discomfort, tolerance and motivation and 
therefore may reflect more meaningful physiological changes in follow up studies  
An additional sub-maximal index of exercise capacity/tolerance that has been 
described in patients with ESRF is the rate of adjustment of VO2 (VO2–on kinetics) in 
response to constant load exercise (Koufaki et al. 2002a). The rate at which VO2 reaches 
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steady state is believed to reflect an integrated physiological ability to meet sudden 
increased demands of energy production. If the oxygen supply at the beginning of a task 
is insufficient to meet O2 demand then there is a delay in reaching steady state and the 
development of early fatigue is more prominent (Grassi 2000).  
In the clinical context constant load exercise tests are usually designed to allow 
patients to reach a steady state for VO2 and as a result most tests are conducted at an 
exercise intensity level below the directly determined LT or GET (VT). The test typically 
comprises a two minute period of “loadless” cycling followed by a “loaded” exercise 
period of ~ six minutes with a subsequent “loadless” pedalling recovery period of a 
further two minutes. Reproducibility data on VO2 kinetics for patients with ESRF 
indicate that there is a substantial variability/error associated with this measure based on 
the average values from 2 transitions performed twice within a week. The reported CV% 
associated with the mean response time kinetics for exercise intensity corresponding to 
90% of GET (VT) was 19.8% (Koufaki et al. 2002b). Non-clinical approaches to this 
type of assessment advocate the use of several “rest-to-work” transitions (at least 4) to 
reduce problems with “signal to noise ratio” (and thus intra-subject variability). However, 
in our experience this is rather impractical with ESRF patients as their fatigue tolerance 
threshold is very low and in most cases they can only tolerate a maximum of 2-3 
transitions in a single assessment day.   
 
Neuromuscular exercise function: Muscle mass and muscle function related measures 
have been also been implicated in predicting disease progress and survival in patients on 
dialysis (Diesel et al. 1990, Beddhu et al 2003, Johansen et al. 2003, Sietsema et al. 
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2004). Accurate and reliable assessment of these parameters is essential therefore for the 
clinically meaningful interpretation of results.  
Muscle function in the dialysis population has been assessed by means of  
measuring absolute dynamic muscle strength (1, 5 or  10 repetition maximums), peak 
force, rate of force development, rate of muscle relaxation, during both isokinetic and 
isometric contractions with or without superimposed electrical stimulation, of nearly all 
main muscle groups (leg extensors, hamstrings, leg abductors and adductors, dorsiflexors, 
forearm muscles, back extensors) (Diesel et al. 1990, Kouidi et al 1998, Gleeson et al. 
2002, Johansen et al. 2003).  Investigators have used a wide variety of assessment 
protocols involving a range of joint angles and/or limb movement speeds. However, 
published information regarding the reliability of muscle performance assessment 
protocols in patients with ESRF is only provided by one research group (Gleeson et al. 
2002). Day-to-day variability expressed as CV% for peak force and rate of force 
development indices during maximal voluntary isometric force production of the knee 
extensor (45 degrees knee flexion angle [0 degrees = full knee extension]) was found to 
be 6.6% and 20.3% respectively. Although it is evident from the literature that the 
application of many muscle performance assessment protocols is feasible in patients with 
renal failure, extra caution still needs to be applied as these people are more prone to 
muscle and tendon ruptures in response to sudden changes in forces. As a result, 
extensive whole body and muscle group-specific warm up exercise and stretches are 
mandated before the execution of any strength assessment protocols.  
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Functional Capacity Assessment 
Performance based functional capacity assessment is an alternative and/or 
complementary way to fully describe physical function in patients with ESRF. Recent 
reports have stressed the observation that functional impairment of patients on dialysis is 
often underestimated by measures of physiological exercise capacity alone (Naish et al. 
2000). Moreover,  it has recently been suggested that the utility of established clinical 
assessments of the nutritional status of patients on dialysis may be enhanced by the 
inclusion of simple and inexpensive measures of functional capacity, that reflect muscle 
mass and muscle function (Mercer et al, 2004).   
Several investigators have reported patients’ functional capacity using the 6 
minute walk test, gait speed tests, stair climb and descent, sit to stand tests (STS), and sit 
and reach test (Mercer et al. 1998, Painter et al. 2000, Johansen et al. 2001, Koufaki et al. 
2002a). Although many of these tests have been fully validated in the general 
rehabilitation and exercise gerontology literature (refer to Aging chapter in this book), 
information about the validity and reproducibility of these tests in the ESRF population is 
available only for STS tests and stair climb and descent (Mercer et al, 1998, Koufaki 
2001). Therefore, subsequent discussion will be restricted to those functional capacity 
tests that have been evaluated in the dialysis population.  
North Staffordshire Royal Infirmary Walk (NSRI walk): This test is composed of 4 
distinctive parts. A walk of 50 metres on flat ground, a stair climb (2 flights; 22 stairs of 
15cm height; total elevation 3.3m), a stair descent, and another 50 m walk back to the 
start point.  Total time and split time for constituent elements should be recorded. The 
patients should be instructed to perform the test as fast as they can. This test has been 
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shown to significantly correlate with VO2 peak (r = -0.83) with a prediction error of 11% 
(Mercer et al. 1998) Therefore, it seems to be a very useful overall assessment of 
functional capacity and in particular the ability to complete ambulatory tasks often 
required in daily living. Reproducibility analysis has shown that the overall CV% for the 
NSRI walk is 8.2% and the CV% separately for the stair climb and stair descent is 11.1% 
and 11.4% respectively (Koufaki 2001) 
Sit-to-Stands: These tests involves rising unassisted from a standard height chair 
(.42 - .46m) and sitting back on the chair as fast as possible. The patients should be 
instructed to keep their hands crossed over their chest so they don’t use them to push 
themselves up and feet should remain on the ground at all times. The patients should also 
be instructed to squat over and touch the chair on the sitting down phase and fully extend 
their knees on the standing up phase. Several variations of the test exist such as STS-5 
and STS-10 which is the fastest time (in seconds) at which patients can complete 5 or 10 
STS cycles (Painter 2000, Johansen 2001) These tests have  been interpreted as indicators 
of muscle power. The reported CV% for STS-5 based on contemporary dialysis patients 
is 15%. STS-60, on the other hand, has been used as an indicator of muscular endurance 
and fatiguability as it requires patients to perform as many STS as they can in 60 seconds. 
The CV% for this version of STS has been reported to be 12.8% (Koufaki 2001). It is not 
unusual that some of the patients may need to take resting breaks especially during the 
STS-60 test. The number of STS-cycles at the exact time of break should be recorded, 
without stopping the timer. Also the time at which the patients resume the test should be 
noted.  
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Summary 
Measures of peak exercise tolerance and/or functional capacity have been shown to be 
related to clinically important outcomes (survival, morbidity and quality of life) in 
patients receiving dialysis-based renal replacement therapy. Given the prognostic 
potential of these factors it is recommended that their measurement should form part of 
the routine assessment (and management) of patients receiving maintenance dialysis 
therapy. If good practice is followed the available literature suggests that exercise 
tolerance and functional capacity assessment of the patient with ESRF is both safe and 
feasible. 
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Table 1: Absolute and Relative contraindications to exercise testing in patients with 
ESRF 
 
ABSOLUTE 
 
RELATIVE 
 
•    Hyper/hypokalaemia 
•  Excess inter-dialytic weight gain 
•      Unstable on dialysis treatment and   
medication regime 
•      Unstable BP 
•      Pulmonary congestion 
•     Peripheral oedema 
•     Unstable cardiac condition 
•     Suspected or known aneurysm 
•  Uncontrolled diabetes 
•   Recent cerebrovascular event 
•      Acute infections 
 
•   History of angina  
•   Resting BP >180/100 or < 100/60mm Hg 
•   Tachyarrhythmias or bradyarrhythmias 
•   Orthostatic BP drop of >20 mmHg with 
symptoms 
•   Resting blood glucose of <5 or > 10 mmol.l-1 
 
 Patients that present with relative contraindications may be exercise tested only after      
      the risk/benefit ratio has been evaluated and close monitoring of vital signs is in place 
 
 The presence of qualified clinical staff is also required. 
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Table 2.  Special considerations for exercise testing of patients with ESRF  
 
•  Assessments are recommended to be performed on non-dialysis days and preferably not 
immediately after a weekend for haemodialysis patients, as this will be the longest interval 
without dialysis 
•  Peritoneal dialysis patients may find it easier to perform tests with their abdominal cavity 
empty of the dialysing fluid, as this may increase pressure on the diaphragm and result in 
more symptoms of breathlessness and chest discomfort.  
•  The arm with the arterio-venous fistula should not be used for BP monitoring or strength 
assessment, as that will give erroneous readings, and may possibly damage the fistula 
•  A complete list of medication regime and doses should be obtained and reviewed before 
each test to ensure informed decisions in case of adverse medication-exercise interaction 
effects  
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Table 3.  Reasons to terminate the exercise test 
 
•   Sustained cardiac arrhythmias 
•   No increases in BP with increasing workload 
•  Evidence of cardiac ischaemia 
•  When BP exceeds 220/110 mmHg 
•  When there is a sudden drop in BP by more than 20mmHg 
•  Symptoms such angina, dizziness, severe breathlessness, lack of 
responsiveness or cooperation to oral and/or visual signs 
•  Equipment failure 
•  Patient’s request 
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